SOG‘LIQNI SAQLASH TIZIMIDA FARMATSEVTIKA XARAJATLARINING IQTISODIY SAMARADORLIGI
Keywords:
farmatsevtika xarajatlari, iqtisodiy samaradorlik, sog‘liqni saqlash tizimi, farmakoiqtisodiyot, xarajat-samaradorlik, generik dori vositalariAbstract
Mazkur maqolada sog‘liqni saqlash tizimida farmatsevtika xarajatlarining iqtisodiy samaradorligi masalalari tahlil qilinadi. Tadqiqotda farmatsevtik xarajatlarning o‘sish dinamikasi, ularning sog‘liqni saqlash tizimidagi ulushi hamda resurslardan oqilona foydalanish masalalari ko‘rib chiqilgan. Shuningdek, farmakoiqtisodiy tahlil usullari, jumladan, xarajat-samaradorlik, xarajat-foydalilik va xarajat-foyda tahlillari asosida dori vositalaridan foydalanish samaradorligi baholanadi. Tadqiqot natijalari farmatsevtika siyosatini takomillashtirish, generik dori vositalarini keng joriy etish hamda narxlarni tartibga solish mexanizmlarini rivojlantirish orqali iqtisodiy samaradorlikni oshirish mumkinligini ko‘rsatadi.
References
Drummond M.F., Sculpher M.J., Claxton K., Stoddart G.L., Torrance G.W. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, 2015.
World Health Organization (WHO). Global Health Expenditure Report. Geneva, 2020.
OECD. Health at a Glance 2019: OECD Indicators. Paris, 2019.
Kaplan R.S., Porter M.E. The Big Idea: How to Solve the Cost Crisis in Health Care // Harvard Business Review, 2011.
Getzen T.E. Health Economics and Financing. Wiley, 2013.
Folland S., Goodman A.C., Stano M. The Economics of Health and Health Care. Routledge, 2017.
Morris S., Devlin N., Parkin D. Economic Analysis in Health Care. Wiley, 2012.
Weinstein M.C., Stason W.B. Foundations of Cost-Effectiveness Analysis // New England Journal of Medicine, 1977.
Arrow K.J. Uncertainty and the Welfare Economics of Medical Care // American Economic Review, 1963.
O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi ma’lumotlari, 2022.
O‘zbekiston Respublikasi Davlat statistika qo‘mitasi hisobotlari, 2023.
Husereau D. et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) // BMJ, 2013.
McGuire A., Henderson J., Mooney G. The Economics of Health Care. Routledge, 2015.
Philips Z. et al. Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment // Pharmacoeconomics, 2006.
Mossialos E., Mrazek M., Walley T. Regulating Pharmaceuticals in Europe. Open University Press, 2004.
